Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease
Public ClinicalTrials.gov record NCT00595244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CSP 127-006 A Phase 3 Clinical Trial to Assess Perfusion and Obstruction Identified by Non-Invasive Technology Using PB127 Ultrasound Contrast Agent in Patients With Suspected Obstructive Coronary Arter Disease
Study identification
- NCT ID
- NCT00595244
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Point Biomedical
- Industry
- Enrollment
- 456 participants
Conditions and interventions
Conditions
Interventions
- PB127 for injectable suspension Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2002
- Primary completion
- Sep 30, 2003
- Completion
- Sep 30, 2003
- Last update posted
- Jul 2, 2008
2002 – 2003
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Michael Morgan, MD | Phoenix | Arizona | 85018 | — |
| Long Beach VA Medical Center Cardiology Division | Long Beach | California | 90822 | — |
| University of California San Diego Division of Cardiology | San Diego | California | 92103 | — |
| San Francisco VA Medical Center NCIRE | San Francisco | California | 94121 | — |
| Washington Hospital Center Cardiovascular Research Institute | Washington D.C. | District of Columbia | 20010 | — |
| The Center for Cardiovascular Studies Kramer & Crouse Cardiology | Shawnee Mission | Kansas | 66204 | — |
| New England Medical Center | Boston | Massachusetts | 02111 | — |
| St. Louis University Medical Center | St Louis | Missouri | 63110 | — |
| The Cleveland Clinic Foundation Department of Cardiology | Cleveland | Ohio | 44195 | — |
| Oregon Health Sciences University | Portland | Oregon | 97239 | — |
| University of Pittsburgh Cardiovascular Institute | Pittsburgh | Pennsylvania | 15213 | — |
| University of Texas Health Sciences Center at San Antonio | San Antonio | Texas | 78229 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
| Harborview Medical Center Department of Cardiology | Seattle | Washington | 98104 | — |
| Northwest Cardiovascular Research Institute Spokane Cardiology | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00595244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2008 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00595244 live on ClinicalTrials.gov.